By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pluristem Therapeutics 

New York  New York    U.S.A.
Phone: n/a Fax: n/a



Company News
Celgene (CELG), Mesoblast (MSB.AX) $45M Deal "Speaks Volumes" About Big Pharma's Cell Therapy Plans, Says Pluristem Therapeutics (PSTI) 4/14/2015 6:27:36 AM
Pluristem Therapeutics (PSTI) Announces Key Strategic Objectives For Development Of PLX-R18 In Hematopoietic Indications 3/24/2015 7:24:19 AM
Pluristem Therapeutics (PSTI) To Present Data At Regenerative Medicine Conferences In Japan And South Korea 3/9/2015 8:05:39 AM
Significant Findings In NIH's Trial Of Pluristem Therapeutics (PSTI)'s PLX-R18 Cells For Treatment Of Acute Radiation Syndrome 2/18/2015 7:43:40 AM
Pluristem Therapeutics (PSTI) Announces Significant New Finding From Its Phase I/II Muscle Injury Trial And Excellent Safety Profile For PLX-PAD Cells At Twelve Months 2/2/2015 7:50:23 AM
Pluristem Therapeutics (PSTI) To Present At Two Cell Therapy Conferences In January 2015 1/13/2015 6:59:57 AM
Updated Coverage Report Focuses On Pluristem Therapeutics (PSTI) 1/12/2015 11:12:38 AM
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 1/12/2015 7:04:41 AM
Pluristem Therapeutics (PSTI) Granted Patent For Foundational Cell Harvesting Technology In South Africa 1/6/2015 7:53:38 AM
New Published Data Show Pluristem Therapeutics (PSTI)'s PLX Cells Protect Neurons 12/22/2014 7:40:56 AM